Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

DSIP

Emideltide, DSIP nonapeptide, Delta sleep-inducing peptide

Quick Stats
Studies 458
Trials 82
Score 1
2003 pubmed 317 citations

Biochemical regulation of non-rapid-eye-movement sleep.

Obal. Ferenc F; Krueger. James M JM

Key Findings

  • DSIP was identified as a potential sleep factor, but its real‑world role in regulating sleep remains unproven.
  • Substances such as adenosine, prostaglandin D2, GHRH, IL‑1, and TNF have strong experimental support for promoting non‑REM sleep.

Practical Outcomes

  • For biohackers, DSIP currently lacks clear evidence for effectiveness, so it isn’t a reliable tool for improving sleep or performance. Focus on well‑studied sleep strategies (e.g., managing caffeine, light exposure, and possibly adenosine‑related approaches) rather than trying DSIP supplementation.

Summary

The paper reviews sleep‑inducing chemicals and says that delta‑sleep‑inducing peptide (DSIP) was once thought to help you fall into deep sleep, but solid evidence that it actually works in the body is still missing. Other molecules like adenosine, prostaglandin‑D2, and certain immune signals have much stronger proof of boosting non‑REM sleep. Overall, the study doesn’t give any new tips or dosages for using DSIP.

Abstract

The concept, that sleep regulatory substances (sleep factors) exist, stems from classical endocrinology and is supported by positive transfer experiments in which tissue fluids obtained from sleepy or sleeping animals elicited sleep when injected into recipient animals. The transfer experiments concluded with the identification of four sleep factors: delta sleep-inducing peptide (DSIP), uridine, oxidized glutathione, and a muramyl peptide. A physiological sleep regulatory role, however, has not been determined for these substances. In contrast, transfer experiments did not play a part in the development of the strong experimental evidence that implicated the currently known sleep factors in sleep regulation. These substances include adenosine, prostaglandin D2 (PGD2), growth hormone-releasing hormone (GHRH), interleukin-1 (IL1) and tumor necrosis factor (TNF). They promote non-REMS in various species, inhibition of their action or endogenous production results in loss of spontaneous sleep, and their synthesis and/or release display variations correlating with sleep-wake activity. Although the source of these substances vary they all enhance sleep by acting in the basal forebrain/anterior hypothalamus--preoptic region. It is also characteristic of these substances that they interact in multiple ways often resulting in mutual stimulation or potentiation of each other. Finally, there is a third group of substances whose significance in sleep regulation is less clear but for which there are two or more lines of evidence suggesting that they may have a role in modulating non-REM sleep (NREMS). This group includes oleamide, cortistatin, cholecystokinin (CCK), insulin, and nitric oxide (NO). More sleep regulatory substances are likely to be discovered in the future although it is a long and difficult process requiring multiple laboratories to generate sufficient convincing data to implicate any one of them in sleep regulation.

Study Information

Provider

pubmed

Year

2003

Date

2003-05-01T00:00:00.000Z

DOI

10.2741/1033

Citations

317